Shandong Xinhua Pharmaceutical (HKG:0719, SHE:000756) reported a net profit attributable to the shareholders of 344.1 million yuan for the first nine months of the year, a decrease of 12.2% compared with 392.0 million yuan a year ago.
Earnings per share were 0.50 yuan, down from 0.57 yuan in the year-ago period, according to a Tuesday filing with the Hong Kong Stock Exchange.
The company's gross revenue stood at 6.73 billion yuan, a 3.6% increase compared with 6.50 billion yuan a year earlier.
The company's Hong Kong-listed shares were down 3% in the recent trading, while its Chinese shares were down 2%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。